Uncategorized Archives - Page 54 of 87 - PsychedelicNewsWire (PNW)

FridayNov 13, 2020 3:24 pm

How Intravenous Ketamine Use Helps Manage and Treat Depression

Patients with treatment resistant depression tolerate ketamine therapy well, with many recording improvements in their depressive symptomatology score (QIDS-SR16) A chart review was carried out among patients with treatment resistant depression who were being treated at the Massachusetts General Hospital Intravenous Ketamine Clinic for Depression, on an outpatient basis. The study results were then published in the “Journal of Affective Disorders.” The researchers assessed the outcomes different outpatients experienced at the ketamine clinic between October 2018 and November 2019. The study involved 85 patients with treatment resistant depression. Before IV ketamine was administered during every visit, the severity of the…

FridayNov 13, 2020 10:46 am

Rritual Superfoods Gains Important USDA Organic Certification for Emerging Industry Superfood Elixirs

Plant-based superfood developer Rritual Superfoods Inc. gained certification from the USDA validating its organic product marketing recently, helping to establish the company’s premium functional food elixirs following their launch in September The initial three product line elixirs, shots and mixes promote wellness by blending select nutraceutical mushrooms with adaptogenic roots to promote the body’s immune and cognitive function, as well as to reduce stress Market analysts predict the overall functional foods industry will achieve revenues of $268 billion by 2027 Functional mushrooms are a still-emerging subsector within the industry, allowing Rritual opportunity to build a following from the ground floor…

ThursdayNov 12, 2020 3:30 pm

Patients with Depression Can Pay for Psychedelic Treatment in Netherlands

Recent discoveries have shown psychedelics to possess many benefits, some of which are known and others that are yet to be discovered. Among those that are known is the discovery that psilocybin can be used to treat depression. Psilocybin, sometimes dubbed magic mushrooms, also helps manage alcohol addiction. Research has shown that when psilocybin therapy is administered to a patient who has depression, it can take months for mild symptoms to reappear again. Over time however, if the therapy isn’t re-administered, the symptoms slowly return. Many governments across the globe have documented various illegal drugs, and in many countries, psychedelics…

WednesdayNov 11, 2020 3:20 pm

No Existing Evidence Suggests Psychedelics Can Alter Religious, Political Beliefs

As psychedelics slowly become more mainstream, some alarmist and exaggerated views of the substances may also be resurfacing. To help give a more grounded perspective, scientific data is used to discredit these extreme views. Today, we look into an article that was published approximately a month ago that argues whether a psychedelic pill can change a person’s religious or political beliefs. The piece brings up ethical questions addressing whether psychedelics ar as effective as psychiatric treatments. The author, Eddie Jacobs, argues that psychedelic therapy may shift a patient’s religious beliefs or political beliefs in another direction. However, this theory is…

TuesdayNov 10, 2020 3:30 pm

What You Should Know About Microdosing Psychedelics

Microdosing is basically consuming a small dose of a psychedelic substance. The dose is normally 5% to 10% of the normal dose of a psychedelic substance. The microdose is consumed on every third day with two days off between dose days. To prevent habitual use and psychological dependence, users should stop usage at the end a month’s period. The most popular psychedelics used for microdosing are psilocybin and LSD. Other compounds that can be consumed at microdose levels include ibogaine, DMT, ayahuasca and mescaline. To make each dose consistent, microdosers may grind the dried fungi or plant because potency varies…

MondayNov 09, 2020 10:45 am

Oregonians Approve Measure to Legalize Psilocybin Therapy

Voters in Oregon have approved a psilocybin ballot initiative, with 1,193,632 people voting yes on the measure and 947,650 individuals voting no. The initiative legalizes psilocybin mushroom use for therapeutic purposes. Under the initiative, adults will be able to acquire psychedelic treatment in an environment that is medically supervised. The measure has no limitations on the conditions required for an individual to be eligible for treatment. Presently, no policies such as this exist in any other state in the United States, although the victory does come at a time when a national movement calling for the decriminalization of various entheogenic…

FridayNov 06, 2020 3:04 pm

Rritual Mushrooms Lauded for Attractive Product Marketing and Growth During Annual Awards

Plant-based superfood developer Rritual Mushrooms Inc. has produced its initial product lineup of three functional mushroom elixirs and powders designed to boost personal wellness The company was recognized by retail marketing agency ECRM for its attractive product presentation and growing success, as judged by national outlets including CVS, Vitamin Shoppe, Amazon and Rite Aid The functional mushroom market is a nascent subsection of the wellness industry ripe with potential for companies that get in on the ground floor as expectations for the industry grow Rritual’s Reishi Relax, Chaga Immune and Lion's Mane Focus formulations are available in 14-stick packs and…

FridayNov 06, 2020 10:15 am

How Much Does the Public Really Know About Psilocybin?

With various cities such as Santa Cruz, Oakland and Denver having decriminalized psilocybin, and Oregon actually passing a ballot measure legalizing magic mushroom therapy, it’s clear that the many therapeutic benefits of psilocybin demonstrated in research are bearing fruit. While this progress may be hard to deny, a large percentage of Americans have no knowledge about the recent strides that have been made in psilocybin research. A study, which focused on newspaper coverage about psilocybin, analyzed how many times psilocybin was mentioned in four different newspapers between January 1, 1989, and December 31, 2019. The analysis also examined three main…

ThursdayNov 05, 2020 3:00 pm

Why LSD Trips Last Long

The findings of research published in the “Cell” journal have demonstrated that once LSD is consumed, a part of the serotonin receptor allows the compound to perch on the brain for up to 12 hours. LSD, which is a psychedelic, alters an individual’s perception and cognition. The potent drug gained popularity globally during the hippie years in the 1960s and 1970s as a recreational drug. However, as it had a high potential for severe physical and psychological dependency as well as for abuse, it was quickly classified as a Schedule 1 drug. Between 1988 and 1993, the Swiss government allowed…

WednesdayNov 04, 2020 3:45 pm

Researchers Look into Creating Powerful Drugs Free from Undesirable Side Effects

Psychedelics, such as magic mushrooms and LSD, have shown to be extremely effective in treating PTSD and depression. With more states working towards decriminalizing psychedelic substances, we can do more than hope that these drugs will become legal alternative forms of therapy in the near future. However, their use is currently restricted because of the hallucinogenic effect they can cause. So how do we reap the benefits of these compounds while avoiding their unwanted side effects? Ron Dror, an associate professor of computer science from Stanford University, has found an answer. The professor and his research team are currently developing…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized